findmyKOL

David Hamrock, MD

Basic profile

Cleveland Clinic

ORCIDNone on fileNPI
RegionCleveland, OH · MidwestSpecialtyDermatologyFocusDermatology
Last active 2011findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2011Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

David Hamrock is a Dermatology physician affiliated with Cleveland Clinic. OpenAlex indexes 6 publications with 251 citations (h-index 4).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
6publications

Distinct works indexed by OpenAlex.

251citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    26.6%
    Folate Analog Metabolic Inhibitor8.7%
    Methotrexate100%
    Part D20 patients
    Nucleoside Metabolic Inhibitor6.9%
    Fluorouracil100%
    Part D56 patients

    + 4 more classes in this area

  • Anti-infectives

    19.7%
    Azole Antifungal10.1%
    Ketoconazole100%
    Part D42 patients
    Nitroimidazole Antimicrobial5.2%
    Metronidazole100%
    Part D31 patients

    + 2 more classes in this area

  • Dermatology

    17.6%
    Corticosteroid10.1%
    Triamcinolone Acetonide100%
    Part D48 patients
    Interleukin-4 Receptor alpha Antagonist4.6%
    Dupixent Syringe100%
    Part D<11 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”